Paper Details
- Home
- Paper Details
Psychiatric Adverse Effects of Montelukast-A Nationwide Cohort Study.
Author: BønnelykkeKlaus, EklöfJosefin, JordanAlexander, MeteranHowraman, SivapalanPradeesh, Stæhr JensenJens-Ulrik, ToennesenLouise Lindhardt, UlrikCharlotte Suppli
Original Abstract of the Article :
BACKGROUND: Recent observational studies suggest that the leukotriene receptor antagonist montelukast may have neuropsychiatric adverse effects; however, results are conflicting. OBJECTIVE: To assess whether montelukast exposure in adults with asthma is associated with onset of neuropsychiatric adv...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.jaip.2023.03.010
データ提供:米国国立医学図書館(NLM)
Montelukast and Neuropsychiatric Adverse Effects: A Nationwide Cohort Study
The human mind is a complex and delicate organ, and it's essential to understand how medications can affect its intricate workings. This research delves into the potential neuropsychiatric side effects of montelukast, a commonly prescribed medication for asthma. The study, conducted on a massive scale using Danish nationwide health registers, provides a comprehensive analysis of the relationship between montelukast exposure and the onset of neuropsychiatric adverse events. The researchers meticulously analyzed the data, using a statistical approach to identify any potential links between montelukast use and neuropsychiatric outcomes. The results of this study are particularly important, as they highlight a potential risk associated with montelukast, especially in younger individuals.
Montelukast Use and Neuropsychiatric Events
The study found a significant association between the initiation of montelukast and the use of neuropsychiatric medications, including antidepressants, antipsychotics, anxiolytics, and medication for attention-deficit/hyperactivity disorder. Interestingly, the researchers observed a higher risk of neuropsychiatric events in younger age groups. This finding is significant, as it raises concerns about the potential impact of montelukast on mental health, especially in individuals with pre-existing neuropsychiatric conditions or vulnerabilities.
Balancing the Benefits and Risks
Montelukast is a valuable medication for managing asthma, but it's crucial to weigh its potential benefits against the risks. This study emphasizes the importance of being vigilant for any neuropsychiatric changes in individuals taking montelukast, particularly in younger patients. Understanding these potential risks can help healthcare providers make informed decisions about prescribing montelukast and ensuring the safety and well-being of their patients.
Dr. Camel's Conclusion
Like the delicate balance of nature, the human body is a complex ecosystem, and medications can sometimes have unforeseen effects. This research serves as a reminder that even seemingly benign medications can have subtle impacts on our mental well-being. It's a valuable contribution to our understanding of drug safety, reminding us to always consider the potential risks and benefits of any medication we take, especially when it comes to our mental health.
Date :
- Date Completed 2023-07-10
- Date Revised 2023-11-20
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.